Follow
Antibodies
Antibodies are blood proteins produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances that the body recognizes as alien, such as bacteria, viruses, and foreign substances in the blood.
SEP 17, 2025 | 8:00 AM
Ivonescimab is a that simultaneously targets programmed cell death protein 1 (PD-1) and vascular endothelial growth factor (VEGF), two key molecules in the tumour microenvironment. It's...
SEP 17, 2025 | 10:00 AM
Antibody reactome profiling is a powerful approach for analyzing antibody-antigen interactions at scale, offering a comprehensive view of an individual’s immune history and current imm...
SEP 11, 2025 | 7:00 AM
ABSTRACT ABSTRACT ABSTRACT Learning Objectives LO 1 LO 2 LO 3 Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing ed...
JUL 10, 2025 | 11:00 AM
Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the g...
JUN 25, 2025 | 8:00 AM
Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Ther...
JUN 10, 2025 | 8:00 AM
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
APR 30, 2025 | 8:00 AM
The purification of proteins and antibodies is a critical process in biotechnology and pharmaceutical industries. Traditional methods often involve single-use materials, leading to high cost...
APR 09, 2025 | 8:00 AM
Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody...
MAR 25, 2025 | 10:00 AM
C.E. CREDITS
• HSV types, anatomical sites and mechanisms of infection/reactivation • Factors in transmission of genital HSV infections • Methods to identify HSV infections • Type-spe...
MAR 25, 2025 | 8:00 AM
Analytical ultracentrifugation is an established method during the development of therapeutic proteins and antibodies and contributes supporting information regarding the size, oligomerizati...
FEB 20, 2025 | 9:00 AM
The webinar on the Zoetis and Genedata collaboration will cover key topics such as the challenges in biotherapeutic research, data management issues, and the need for centralized data. Atten...
NOV 19, 2024 | 8:00 AM
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
NOV 06, 2024 | 10:00 AM
The discovery and optimization of antibodies, whether through traditional methods or with the assistance of artificial intelligence, necessitates rapid and reliable data generation. Here we...
OCT 30, 2024 | 11:00 AM
Charge heterogeneity in monoclonal antibodies can negatively impact binding affinity and potency, so it is critical to ensure that individual charge variants of biotherapeutic molecules are...
OCT 24, 2024 | 8:00 AM
Analyzing protein expression in biological samples has traditionally been challenging and often poorly reproducible. While methods like western blot have been around for decades, Simple West...
On Demand
C.E. CREDITS
Gene therapy has experienced an increasing number of successful human clinical trials, leading to 6 FDA approved products using delivery vectors based on adeno-associated viruses (AAV). Thes...
OCT 16, 2024 | 10:30 AM
C.E. CREDITS
The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to gen...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
OCT 01, 2024 | 7:00 AM
The human antibody repertoire, or reactome, is a vast and dynamic network of antibody-antigen interactions that plays a crucial role in health and disease. Understanding the complexity of th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
OCT 01, 2024 | 7:00 AM
The human antibody repertoire, or reactome, is a vast and dynamic network of antibody-antigen interactions that plays a crucial role in health and disease. Understanding the complexity of th...